Pozen secures second patent for its drug technology
Research Triangle Park, N.C. — Pozen (Nasdaq: POZN) hasn't gotten any pain relief from the FDA recently - but it has from the U.S. Patent and Trademark Office....
Please Log In to add a comment.
Latest for Insiders
- Survey: More Triangle startups to cut spending, reduce hiring
- San Francisco firm acquires Raleigh-based social marketer Expion
- IBM layoffs? Top finance exec sees more 'workforce rebalancing'
- Tech giants keep spending big on lobbying in DC
- 'Humbled' veteran Quintiles exec gears up for new role as Q2 CEO
- Will there be layoffs as well as new jobs as Quintiles' Q2 launches?
- The Startup Factory takes its first step toward going statewide
- State to add 105,000 jobs this year, jobless rate to fall says NCSU economist
- A nearly $2B IPO adds to legacy of Lenovo's founder
- Remembering Triangle's first 'disruptors' from 2007 - and warnings still relevant today